Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Arthroplasty|December 4, 2004
Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplastyDariusz Ladon, Ann Doherty, Roger Newson, et al.
Mutation Research|March 23, 2007
Genotoxic effects of particles of surgical cobalt chrome alloy on human cells of different age in vitroIraklis Papageorgiou, Zhirong Yin, Dariusz Ladon, et al.
British Journal of Haematology|June 18, 2010
The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II studyStephen A Schey, Gareth J Morgan, Karthik Ramasamy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2018
Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic EffectsChristos Georgiadis, Roland Preece, Lauren Nickolay, et al.
Nature Communications|August 14, 2020
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich SyndromeRajeev Rai, Marianna Romito, Elizabeth Rivers, et al.
Nature Communications|November 26, 2021
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression programSiobhan Rice, Thomas Jackson, Nicholas T Crump, et al.
Blood Cancer Journal|April 11, 2023
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasmsMithun Vinod Shah, Elizabeth Ngoc Hoa Tran, Syed Shah, et al.
Haematologica|February 29, 2012
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disordersFiona M Ross, Hervé Avet-Loiseau, Geneviève Ameye, et al.
Blood Advances|March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutationsMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Blood Cancer Journal|May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohortMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Pageof 2